graft-versus-host disease

[Blood] Investigators reported results of a Phase III trial to evaluate the efficacy of omidubicel compared to standard umbilical cord blood transplantation.

[Blood Advances] Investigators enrolled 38 patients with hematologic malignancies scheduled to undergo MMUD-HCT onto 1 of 2 conditioning strata: myeloablative using fludarabine and fractionated total body irradiation or reduced intensity with fludarabine/melphalan.

[International Journal of Laboratory Hematology] Researchers investigated the impact of erythroblasts on transplant outcomes on 225 adult patients who underwent single-unit cord blood transplantation at our single institute.

[International Journal of Hematology] Scientists explored the incidence and risk factors of late-onset hemorrhagic cystitis in patients undergoing single umbilical cord blood transplantation for hematological malignancies.

[Bone Marrow Transplantation] Investigators compared 32 patients who underwent unrelated donor (UD) hematopoietic stem cell transplantation (HSCT) using cryopreserved peripheral blood stem cells (PBSC) during the COVID-19 pandemic with 32 patients who underwent UD HSCT using fresh PBSC in the previous period.

[Journal of Clinical Investigation] Scientists review selected recent advances both in preclinical experimental transplantation and translational human studies, including new insights into human immunology, the microbiome, and regenerative medicine.